D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.93% |
| 2 | Consumer Discretionary | 10.48% |
| 3 | Healthcare | 8.56% |
| 4 | Communication Services | 8.41% |
| 5 | Financials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ROSS.U
1626
DELISTED
Ross Acquisition Corp II Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
ROSS.U
| $5.74M | 0.01% |
+576,266
| New | +$5.74M |
|
1627
DraftKings
DKNG
$12.1B
| $5.73M | 0.01% |
93,490
+8,846
| +10% | +$531K |
|
1628
Iridium Communications
IRDM
$4.82B
| $5.72M | 0.01% |
138,730
+106,288
| +328% | +$4.65M |
|
1629
Bentley Systems
BSY
$10.8B
| $5.72M | 0.01% |
121,915
+45,526
| +60% | +$2.08M |
|
1630
Regions Financial
RF
$26.5B
| $5.71M | 0.01% |
276,389
-38,621
| -12% | -$755K |
|
1631
PUT
Phillips 66
PSX
$82.6B
| $5.71M | 0.01% |
70,000
-105,600
| -60% | -$8.29M |
|
|
TEN
1632
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $5.7M | 0.01% |
532,065
+342,190
| +180% | +$3.74M |
|
1633
CALL
Johnson & Johnson
JNJ
$650B
| $5.7M | 0.01% |
34,700
-5,300
| -13% | -$858K |
|
1634
Quanta Services
PWR
$88.4B
| $5.68M | 0.01% |
64,604
-260,947
| -80% | -$20.8M |
|
1635
GrafTech
EAF
$202M
| $5.68M | 0.01% |
+46,472
| New | +$5.37M |
|
1636
Principal Financial Group
PFG
$24.7B
| $5.66M | 0.01% |
94,456
-163,377
| -63% | -$9.11M |
|
1637
PUT
Broadcom
AVGO
$1.83T
| $5.66M | 0.01% |
122,000
+1,000
| +0.8% | +$46.2K |
|
1638
Johnson Controls International
JCI
$85B
| $5.65M | 0.01% |
94,665
-1,112,190
| -92% | -$61.1M |
|
1639
Medpace
MEDP
$16.2B
| $5.63M | 0.01% |
34,301
-50,253
| -59% | -$7.69M |
|
1640
CALL
Synchrony
SYF
$25B
| $5.63M | 0.01% |
138,400
-122,500
| -47% | -$4.72M |
|
|
ZEN
1641
DELISTED
ZENDESK INC
ZEN
| $5.63M | 0.01% |
42,426
-249,867
| -85% | -$35.8M |
|
1642
CALL
Valero Energy
VLO
$88.8B
| $5.58M | 0.01% |
78,000
-81,600
| -51% | -$5.55M |
|
|
NGC.U
1643
DELISTED
Northern Genesis Acquisition Corp. III Units, each consisting of one share of common stock and one-quarter of one redeemable warrant
NGC.U
| $5.57M | 0.01% |
+558,449
| New | +$5.55M |
|
1644
Astronics
ATRO
$3.35B
| $5.57M | 0.01% |
370,331
-269,471
| -42% | -$3.48M |
|
1645
System1
SST
$15.6M
| $5.56M | 0.01% |
55,830
+15,850
| +40% | +$1.69M |
|
1646
CALL
Invesco
IVZ
$13.3B
| $5.55M | 0.01% |
220,000
+80,000
| +57% | +$1.79M |
|
1647
CALL
Citizens Financial Group
CFG
$30.5B
| $5.54M | 0.01% |
125,600
+88,700
| +240% | +$3.69M |
|
1648
Vanguard Global ex-US Real Estate ETF
VNQI
$3.53B
| $5.53M | 0.01% |
99,110
-29,423
| -23% | -$1.61M |
|
1649
EXL Service
EXLS
$4.61B
| $5.52M | 0.01% |
306,200
+169,895
| +125% | +$2.9M |
|
1650
CALL
lululemon athletica
LULU
$13.7B
| $5.52M | 0.01% |
18,000
-93,700
| -84% | -$30.8M |
|
Similar funds
D.E. Shaw & Co's Q1 2021 Portfolio in Review
As of Q1 2021, D.E. Shaw & Co held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
D.E. Shaw & Co withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Baidu worth $627M.
- D.E. Shaw & Co's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- D.E. Shaw & Co added most to Tesla in Q1 2021, an estimated $862M increase.
- D.E. Shaw & Co's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- D.E. Shaw & Co fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- D.E. Shaw & Co's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- D.E. Shaw & Co opened 825 new positions and closed 730 in Q1 2021.
- D.E. Shaw & Co's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.